Systemic allergy to human insulin and its rapid and long acting analogs: Successful treatment by continuous subcutaneous insulin lispro infusion

Diabetes and Metabolism

Volumn 31, Issue 4 I, 2005, Pages 391-400

  Castera V ^a   Dutour Meyer, A ^a   Koeppel, M C ^a   Petitjean, C ^a   Darmon, P ^a  

^a HÔPITAL NORD   (France)

Author keywords

Allergy to insulin; IgE detection; Insulin analogs; Tolerance induction

Indexed keywords

ACARBOSE; ANTIHISTAMINIC AGENT; GLIPIZIDE; GLUCOR; GLUCOSE; HUMALOG MIX 25; HUMAN INSULIN; IMMUNOGLOBULIN E ANTIBODY; INSULIN ASPART; INSULIN DERIVATIVE; INSULIN GLARGINE; INSULIN LISPRO; METFORMIN; OZIDIA; REPAGLINIDE; UNCLASSIFIED DRUG;

ADULT; ANAPHYLACTIC SHOCK; CASE REPORT; CLINICAL FEATURE; DELAYED HYPERSENSITIVITY; DESENSITIZATION; DRUG HYPERSENSITIVITY; DRUG INFUSION; GLUCOSE BLOOD LEVEL; HUMAN; IMMEDIATE TYPE HYPERSENSITIVITY; IMMUNOLOGICAL TOLERANCE; INTRACUTANEOUS TEST; LOW CALORY DIET; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; RARE DISEASE; REVIEW; SYMPTOMATOLOGY; SYSTEMIC DISEASE; TREATMENT OUTCOME;

EID: 25844456733     PISSN: 12623636     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1262-3636(07)70210-0     Document Type: Review

References (49)

1. Nagai T, Nagai Y, Tomizawa T, Mori M. Immediate-type human insulin allergy successfully treated by continuous subcutaneous insulin infusion. Intern Med 1997;36:575-8
2. Kumar D. Lispro analog for treatment of generalized allergy to human insulin. Diabetes Care 1997;20:1357-9
3. Gonzalo MA, De Argua D, Revenga F, Garcia JM, Diaz J, Morales F. Cutaneous allergy to human (recombinant DNA) insulin. Allergy 1998;53:106-7
4. Pratt EJ, Miles P, Kerr D. Localized insulin allergy treated with continuous subcutaneous insulin. Diabet Med 2001;18:515-6
5. Naf S, Esmatjes E, Recasens M, Valero A, Halperin I, Levy I, Gomis R. Continuous subcutaneous insulin infusion to resolve an allergy to human insulin. Diabetes Care 2002;25:634-5
6. Barranco R, Herrero T, Tornero P, et al. Systemic allergic reaction by a human insulin analog. Allergy 2003;58:536-7
7. Fernandez L, Duque S, Montalban C, Bartolome B. Allergy to human insulin. Allergy 2003;58:1317
8. Takata H, Kumon Y, Osaki F, et al. The human insulin analogue aspart is not the almighty solution for insulin allergy. Diabetes Care 2003;26:253-4
9. Imiela A, Tavernier J-Y, Carotte-Lefebvre I, Deverny F, Delaporte E, Lamblin C. Allergy to human recombinant insulin: 3 cases with generalized immediate allergic reaction. Rev Franc All Immunol Clin 2003;43:165-9
10. Durand-Gonzalez KN, Guillausseau N, Pecquet C, Gayno JP. Glargine insulin is not an alternative in insulin allergy. Diabetes Care 2003;26:2216
11. JiXiong X, Jianying L, Yulan C, Huixian C. The human insulin analog aspart can induce insulin allergy. Diabetes Care 2004;27:2084-5
12. Vernassière C, Tréchot P, Guerci B, Commun N, Schmutz JL, Barbaud A. Deux premiers cas de sensibilisation retardée aux insulines humaines recombinantes modifiées. Ann Dermatol Venereol [Abstract] 2004;13:P1
13. Schernthaner G. Immunogenicity and allergenic potential of animal and human insulins. Diabetes Care 1993;16:55-65
14. rd edition. Gell PGH, Coombs RAA, Lachmann PJ. Eds Oxford, London, Edinburgh, Blackwell 1975;761-81
15. Ganz MA, Unterman T, Roberts M, et al. Resistance and allergy to recombinant human insulin. J Allergy Clin Immunol 1990;86:45-51
16. Silva ME, Mendes MJ, Ursich MJ, et al. Human insulin allergy-immediate and late type III reactions in a long-standing IDDM patient. Diabetes Res Clin Pract 1997;36:67-70
17. Frigerio C, Aubry M, Gomez F, et al. Desensitization-resistant insulin allergy. Allergy 1997;52:238-9
18. Loeb JA, Herold KC, Barton KP, Robinson LE, Jaspan JB. Systematic approach to diagnosis and management of biphasic insulin allergy with local anti-inflammatory agents. Diabetes Care 1989;12:421-3
19. Fineberg NS, Fineberg SE, Anderson JH, Birkett MA, Gibson RG, Hufferd S. Immunologic effects of insulin lispro [Lys (B28), Pro (B29) human insulin] in IDDM and NIDDM patients previously treated with insulin. Diabetes 1996;45:1750-4
20. Messaad D, Outtas O, Demoly P. Hypersensitivity to insulin. Presse Med 2004;33:631-8
21. De Schazo RD, Mather P, Grant W, et al. Evaluation of patients with local reactions to insulin with skin tests and in vitro techniques. Diabetes Care 1987;10:330-6
22. Ratner RE, Phillips TM, Steiner M. Persistent cutaneous insulin allergy resulting from high-molecular-weight insulin aggregates. Diabetes 1990;39:728-33
23. Grammer. Insulin Allergy. Clin Rev Allergy 1986;4:189-200
24. Fineberg SE, Huang J, Brunelle R, Gulliya KS, Anderson JH Jr. Effect of long-term exposure to insulin lispro on the induction of antibody response in patients with type 1 or type 2 diabetes. Diabetes Care 2003;26:89-96
25. Lindholm A, Jensen LB, Home PD, Raskin P, Boehm BO, Rastam J. Immune responses to insulin aspart and biphasic insulin aspart in people with type 1 and type 2 diabetes. Diabetes Care 2002;25:876-82
26. Pieber TR, Eugene-Jolchine I, Derobert E. Efficacy and safety of HOE 901 versus NPH insulin in patients with type 1 diabetes. The European Study Group of HOE 901 in type 1 diabetes. Diabetes Care 2000;23:157-62
27. Ottesen JL, Nilsson P, Jami J, et al. The potential immunogenicity of human insulin and insulin analogues evaluated in a transgenic mouse model. Diabetologia 1994;37:1178-85
28. Zwickl CM, Smith HW, Zimmermann JL, Wierda D. Immunogenicity of biosynthetic human LysPro insulin compared to native-sequence human and purified porcine insulins in rhesus monkeys immunized over a 6-week period. Arzneimittelforschung 1995;45:524-8
29. Dahl-Jorgensen K, Torjesen P, Hanssen KF, Sandvik L, Aagenaes O. Increase in insulin antibodies during continuous subcutaneous insulin infusion and multiple-injection therapy in contrast to conventional treatment. Diabetes 1987;36:1-5
30. Dykewicz MS, Kim HW, Orfan N, Yoo TJ, Lieberman P. Immunologic analysis of anaphylaxis to protamine component in neutral protamine Hagedorn human insulin. J Allergy Clin Immun 1994;93: 117-25
31. Bollinger ME, Hamilton RG, Wood RA. Protamine allergy as a complication of insulin hypersensitivity: A case report. J Allergy Clin Immunol 1999;104:462-5
32. Blanco C, Castillo R, Quiralte J, et al. Anaphylaxis to subcutaneous neutral protamine Hagedorn insulin with simultaneous sensitization to protamine and insulin. Allergy 1996;51:421-4
33. Panczel P, Hosszufalusi N, Horvath MM, Horvath A. Advantage of insulin lispro in suspected insulin allergy. Allergy 2000;55:409-10
34. Feinglos MN, Jegasothy BV. "Insulin" allergy due to zinc. Lancet 1979;1:122-4
35. Lluch-Bernal M, Fernandez M, Herrera-Pombo JL, Sastre J. Insulin lispro, an alternative in insulin hypersensitivity. Allergy 1999;54: 186-7
36. Lee AY, Chey WY, Choi J, Jeon JS. Insulin-induced drug eruptions and reliability of skin tests. Acta Derm Venereol 2002;82:114-7
37. Airaghi L, Lorini M, Tedeschi A. The insulin analog aspart: a safe alternative in insulin allergy. Diabetes Care 2001;24:2000
38. Yasuda H, Nagata M, Moriyama H, et al. Human insulin analog insulin aspart does not cause insulin allergy. Diabetes Care 2001;24: 2008-9
39. Eapen SS, Connor EL, Gern JE. Insulin desensitization with insulin lispro and an insulin pump in a 5-year-old child. Ann Allergy Asthma Immunol 2000;85:395-7
40. Hermoso F, Vazquez M, Chaves G, Revigerio J, Andion R. Generalized allergy to human insulin treated with insulin lispro [Abstract]. Diabetologia 1997;40:A349
41. Abraham MR, al-Sharafi BA, Saavedra GA, Khardori R. Lispro in the treatment of insulin allergy. Diabetes Care 1999;22:1916-7
42. Bodtger U, Wittrup M. A rational clinical approach to suspected insulin allergy: status after five years and 22 cases. Diabet Med 2005;22: 102-6
43. Moriyama H, Nagata M, Fujihira K, et al. Treatment with human analog (GlyA21, ArgB31, ArgB32) insulin glargine (HOE901) resolves a generalized allergy to human insulin in type 1 diabetes. Diabetes Care 2001;24:411-2
44. Galloway JA, deSchazo RD. Complications of insulin treatments. In Diabetes Mellitus: Theory and practice. Ellenberg M, Rifklin H, Eds. New Hyde Park, NY Med Exam 1990;506-508
45. Radermecker R-P, Scheen A-J. Treatment of allergy to insulin using continuous subcutaneous insulin infusion with short-acting insulin analogues. Infusystems International, 2004,3
46. Valentini U, Cimino A, Rocca L, Pelizzari R, Rotondi A, Tosoni C. CSII in management of insulin allergy. Diabetes Care 1988;11: 97-8
47. Durand-Gonzalez KN, Guillausseau N, Anciaux ML, Hentschel V, Gayno JP. Allergy to insulin in a woman with gestational diabetes mellitus: transient efficiency of continuous subcutaneous insulin lispro infusion. Diabetes Metab 2003;29:432-4
48. Sola-Gazagnes A, Pecquet C, Radermecker R, et al. Successful treatment of insulin allergy in a type 1 diabetic patient by means of constant subcutaneous pump infusion of insulin. Diabetes Care 2003;26:2961-2
49. Oh HK, Provenzano R, Hendrix J, el-Nachef MW. Insulin allergy resolution following pancreas transplantation alone. Clin Transplant 1998;12:593-5